This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer ...

The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...

Market has emerged as a rapidly expanding segment within the oncology diagnostics and liquid biopsy landscape. Circulating Tumor Cells are cancerous cells that detach from primary or metastatic tumors ...

One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder ...

Given the success of the previous collection, <a href=" Biomarkers of Cardiometabolic Disease, and the new advances in the field, we are pleased to announce the launch of Volume II.

About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

Foundation Medicine is one of the chief contributors to ComboMATCH, an initiative to test biomarker-targeted cancer treatment combinations ...

Hepatobiliary and pancreatic tumors represent a critical area of oncological research due to their aggressive nature, limited ...